PH24749A - Piperidine compounds, pharmaceutical composition and method of use thereof - Google Patents

Piperidine compounds, pharmaceutical composition and method of use thereof

Info

Publication number
PH24749A
PH24749A PH36012A PH36012A PH24749A PH 24749 A PH24749 A PH 24749A PH 36012 A PH36012 A PH 36012A PH 36012 A PH36012 A PH 36012A PH 24749 A PH24749 A PH 24749A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
piperidine compounds
piperidine
compounds
pharmaceutical
Prior art date
Application number
PH36012A
Other languages
English (en)
Inventor
Jorgen Drejer
Palle Jacobsen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK523286A external-priority patent/DK523286D0/da
Priority claimed from DK323487A external-priority patent/DK323487D0/da
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of PH24749A publication Critical patent/PH24749A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH36012A 1986-11-03 1989-10-30 Piperidine compounds, pharmaceutical composition and method of use thereof PH24749A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK523286A DK523286D0 (da) 1986-11-03 1986-11-03 Piperidine forbindelser, deres fremstilling og anvendelse
DK323487A DK323487D0 (da) 1987-06-25 1987-06-25 Piperidin forbindelser, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
PH24749A true PH24749A (en) 1990-10-01

Family

ID=26066954

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36012A PH24749A (en) 1986-11-03 1989-10-30 Piperidine compounds, pharmaceutical composition and method of use thereof

Country Status (14)

Country Link
US (3) US4877799A (de)
EP (1) EP0266574B1 (de)
JP (1) JP2633872B2 (de)
KR (1) KR880006193A (de)
AU (1) AU602735B2 (de)
CA (1) CA1323367C (de)
DE (1) DE3788709T2 (de)
ES (1) ES2061463T3 (de)
FI (1) FI92821C (de)
IE (1) IE66332B1 (de)
IL (1) IL84021A (de)
NZ (1) NZ222155A (de)
PH (1) PH24749A (de)
PT (1) PT86066B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
AT391269B (de) * 1988-12-30 1990-09-10 Burghart Kurt Pharmazeutische zubereitung
DK640289D0 (da) * 1989-12-18 1989-12-18 Ferrosan As Ny heterocyklisk kemi
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments
ES2102295B1 (es) * 1994-03-18 1998-04-01 Ferrer Int Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
US5723475A (en) * 1995-02-28 1998-03-03 Suntory Limited Arylpiperidine and arylpiperazine derivatives and medicament containing the same
CN1068597C (zh) * 1995-05-17 2001-07-18 诺沃挪第克公司 制备4－芳基－哌啶衍生物的方法
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1394160A1 (de) 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Verfahren zur Herstellung von kristallinem Paroxetin-Hydrochlorid
WO1998003172A1 (en) * 1996-07-22 1998-01-29 Suntory Limited Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
AU710594B2 (en) 1996-07-22 1999-09-23 Asubio Pharma Co., Ltd. Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6110937A (en) 1997-04-03 2000-08-29 Syntex Usa, Inc. Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain
US6180648B1 (en) * 1997-04-07 2001-01-30 Biostream Therapeutics, Inc. Analogs of cocaine
SK283394B6 (sk) 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
EP1318988A2 (de) * 2000-09-11 2003-06-18 Sepracor, Inc. Liganden für monoamin rezeptoren und transporter, und verwendungsmethoden dafür (neurotransmission)
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
JP2007509168A (ja) * 2003-10-22 2007-04-12 ジョージタウン ユニヴァーシティー ドーパミン、ノルエピネフリンおよびセロトニンの輸送体に選択的なヘテロ環式化合物およびその治療的使用
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE2549999A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Piperidin-derivate und verfahren zu ihrer herstellung
DK149624C (da) * 1983-03-07 1987-02-02 Ferrosan As Fremgangsmaade til fremstilling af (+)-trans-3-((4-methoxyphenoxy)-methyl)-1-methyl-4-phenylpiperidin eller et farmaceutisk acceptabelt salt heraf ud fra en blanding af enantiomererne
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
US4593036A (en) * 1984-02-07 1986-06-03 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator
GB8431478D0 (en) * 1984-12-13 1985-01-23 Beecham Group Plc Compounds
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use

Also Published As

Publication number Publication date
KR880006193A (ko) 1988-07-22
IL84021A0 (en) 1988-02-29
DE3788709T2 (de) 1994-04-28
US5019582A (en) 1991-05-28
FI92821B (fi) 1994-09-30
NZ222155A (en) 1990-08-28
PT86066B (pt) 1990-11-07
PT86066A (en) 1987-12-01
EP0266574A3 (en) 1988-07-20
JPS63126866A (ja) 1988-05-30
IE872561L (en) 1988-05-03
ES2061463T3 (es) 1994-12-16
EP0266574A2 (de) 1988-05-11
AU8048287A (en) 1988-05-05
US4985446A (en) 1991-01-15
AU602735B2 (en) 1990-10-25
EP0266574B1 (de) 1994-01-05
FI874459A0 (fi) 1987-10-09
IL84021A (en) 1993-02-21
DE3788709D1 (de) 1994-02-17
FI874459A7 (fi) 1988-05-04
US4877799A (en) 1989-10-31
CA1323367C (en) 1993-10-19
FI92821C (fi) 1995-01-10
IE66332B1 (en) 1995-12-27
JP2633872B2 (ja) 1997-07-23

Similar Documents

Publication Publication Date Title
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
PH23357A (en) Cyclosporin compound,pharmaceutical composition containing said compound and method of use thereof
GB8613688D0 (en) Pharmaceutical composition
IL79572A0 (en) 2-thiomethyl-substituted-1,4-dihydropyridines,method for their preparation and pharmaceutical compositions containing them
PH24719A (en) Cephem compound, pharmaceutical composition containing said compound and method of use thereof
NZ221621A (en) Piperidine derivatives and pharmaceutical compositions
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
PH22821A (en) Phenyl butenamide, pharmaceutical composition containing said compound and method of use thereof
PH24180A (en) Macrolide compounds,pharmaceutical composition containing said compound and method of use thereof
PH23341A (en) Morphinane derivatives,pharmaceutical composition containing said compounds and method of use thereof
IL82205A (en) Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
PH24326A (en) Substituted 3,4-dihydro-2h-benzopyrans,pharmaceutical compositions containing same and method of use thereof
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
PH24093A (en) Macrolide compounds,pharmaceutical composition containing same and method of use thereof
EP0264091A3 (en) 3-propenylcephem derivative, preparation thereof, chemical intermediates therein, pharmaceutical composition and use
GB2176473B (en) Preparation of 4-amino-2,2,6, 6-tetramethylpiperidine
PH23384A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions and method use thereof
DE3664635D1 (en) 7-hydroxyguanine compounds, process for preparing said compounds, pharmaceutical composition, and use thereof
PH24290A (en) Pyrimidine derivatives,pharmaceutical compositions containing them and method of use thereof
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof
PH24690A (en) 8 alpha(-acylaminoergoline, pharmaceutical composition containing said compound and method of use thereof
PH24246A (en) New 1-aryloxy-dihydrobenzothiadiazinylalkylamino-alkanes,pharmaceutical compositions containing same and method of use thereof
IL81292A0 (en) Dihydropyridines and pharmaceutical compositions containing them
PH25227A (en) Aromatic w-alkylamino-tetrahydro-6h-1,3-thiazin-6-one derivatives, pharmaceutical composition containing same and method of use thereof